P/E ratio for Teleflex (TFX)
P/E ratio as of March 2023 (TTM): 31.9
According to Teleflex's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 31.8877. At the end of 2021 the company had a P/E ratio of 31.7.
P/E ratio history for Teleflex from 2001 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | 31.7 | -44.43% |
| 2020 | 57.0 | 51.28% |
| 2019 | 37.7 | -36% |
| 2018 | 58.9 | -20.02% |
| 2017 | 73.6 | 150.33% |
| 2016 | 29.4 | 31.54% |
| 2015 | 22.4 | |
| 2013 | 25.6 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.4 | -29.74% | 🇺🇸 USA |
 Abiomed ABMD | 64.8 | 103.21% | 🇺🇸 USA |
 Becton Dickinson BDX | 45.3 | 42.19% | 🇺🇸 USA |
 Boston Scientific BSX | 108 | 237.82% | 🇺🇸 USA |
 General Electric GE | -227 | -812.41% | 🇺🇸 USA |
 Cooper Companies COO | 45.6 | 42.87% | 🇺🇸 USA |
 Merit Medical MMSI | 55.2 | 73.22% | 🇺🇸 USA |
 AngioDynamics ANGO | -15.1 | -147.35% | 🇺🇸 USA |
 Integra LifeSciences IART | 25.6 | -19.74% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.